| pubmed-article:10513636 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10513636 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:10513636 | lifeskim:mentions | umls-concept:C0020205 | lld:lifeskim |
| pubmed-article:10513636 | lifeskim:mentions | umls-concept:C1334691 | lld:lifeskim |
| pubmed-article:10513636 | lifeskim:mentions | umls-concept:C0023828 | lld:lifeskim |
| pubmed-article:10513636 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10513636 | pubmed:dateCreated | 1999-11-24 | lld:pubmed |
| pubmed-article:10513636 | pubmed:abstractText | The inhibitory effects of the hybrid liposomes on the growth of B-16 melanoma cells in vitro and in vivo were examined. The 50% inhibitory concentration of the hybrid liposomes composed of 90 mol% dimyristoylphosphatidylcholine (DMPC) and 10 mol% polyoxyethylenedodecyl ether (C12(EO)10) was one-twelfth of that of DMPC liposomes. It was noteworthy that for the first time significantly prolonged survival was obtained using a mouce model of carcinoma after the administration of the hybrid liposomes of 90 mol% DMPC/10 mol% C12(EO)n (n=10 or 23) without antitumor drugs. | lld:pubmed |
| pubmed-article:10513636 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10513636 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10513636 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10513636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10513636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10513636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10513636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10513636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10513636 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10513636 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10513636 | pubmed:issn | 0918-6158 | lld:pubmed |
| pubmed-article:10513636 | pubmed:author | pubmed-author:MatsumotoYY | lld:pubmed |
| pubmed-article:10513636 | pubmed:author | pubmed-author:MiyagiMM | lld:pubmed |
| pubmed-article:10513636 | pubmed:author | pubmed-author:TsuzakiKK | lld:pubmed |
| pubmed-article:10513636 | pubmed:author | pubmed-author:KanneWW | lld:pubmed |
| pubmed-article:10513636 | pubmed:author | pubmed-author:UeokaRR | lld:pubmed |
| pubmed-article:10513636 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10513636 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:10513636 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10513636 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10513636 | pubmed:pagination | 1013-4 | lld:pubmed |
| pubmed-article:10513636 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:meshHeading | pubmed-meshheading:10513636... | lld:pubmed |
| pubmed-article:10513636 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10513636 | pubmed:articleTitle | Chemotherapy with hybrid liposomes for melanomatosis. | lld:pubmed |
| pubmed-article:10513636 | pubmed:affiliation | Graduate Course of Applied Chemistry, Kumamoto Institute of Technology, Japan. | lld:pubmed |
| pubmed-article:10513636 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10513636 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
